See also this year's filing and all EDGAR filings for this company.
PDF Report 0001349929_2016_Vyant_Bio_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Assets', 'missing_ratio': 0.2516841251366698, 'aggregate_val': 42434000, 'exp_sum': 56706000, 'exp_to_value': {'IntangibleAssets': 12029000, 'AssetsNonCurrent': 14272000, 'AssetsCurrent': 23424000, 'PropertyPlantAndEquipment': 4738000, 'remainder_Assets': 2243000}} |
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Assets', 'missing_ratio': 0.23018535141178878, 'aggregate_val': 48884000, 'exp_sum': 63501000, 'exp_to_value': {'IntangibleAssets': 12029000, 'AssetsNonCurrent': 14617000, 'AssetsCurrent': 28198000, 'PropertyPlantAndEquipment': 6069000, 'remainder_Assets': 2588000}} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001349929')"} |
Graph
Absolute values for 0001349929, Vyant Bio Inc
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 12,029,000 |
| 1 | AssetsNonCurrent | 14,617,000 |
| 2 | AssetsCurrent | 28,198,000 |
| 3 | PropertyPlantAndEquipment | 6,069,000 |
| 4 | remainder_Assets | -12,029,000 |
| 5 | LongTermLiabilities | 0 |
| 6 | LiabilitiesCurrent | 9,865,000 |
| 7 | remainder_Liabilities | 6,002,000 |
| 8 | LaborExpense | 0 |
| 9 | CostOfGoodsAndServicesSold | 14,098,000 |
| 10 | GeneralAndAdministrativeExpense | 14,567,000 |
| 11 | GoodwillImpairmentLoss | 0 |
| 12 | OperatingCostsAndExpenses | 0 |
| 13 | DepreciationDepletionAndAmortization | 0 |
| 14 | SellingAndMarketingExpense | 5,269,000 |
| 15 | ResearchAndDevelopmentExpense | 5,483,000 |
| 16 | remainder_Expenses | -1,184,000 |
| 17 | remainder_Revenues | 18,040,000 |
| 18 | remainder_NetIncome | 9,000 |
| 19 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 48,884,000 |
| 1 | Liabilities | 15,867,000 |
| 2 | Expenses | 38,233,000 |
| 3 | Revenues | 18,040,000 |
| 4 | StockholdersEquity | 33,017,000 |
| 5 | NetIncome | -20,184,000 |
| 6 | ComprehensiveNetIncome | -20,184,000 |
| 7 | BaseVar | 60,516,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.855 |
| 9 | EconomicCapitalRatio | 1.61 |
Edgar->Model Mapping
Feature Distribution
Change over Time
